These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9820005)
1. [Peroxisomes and peroxisome proliferators. Specific environmental poisons and therapeutic agents affecting lipid metabolism and hormone release]. Hammer TA; Waldum HL Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3603-8. PubMed ID: 9820005 [TBL] [Abstract][Full Text] [Related]
2. Hepatic peroxisome proliferation in rodents and its significance for humans. Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416 [TBL] [Abstract][Full Text] [Related]
3. [Proliferation of peroxisomes and the hepatocarcinogenic process]. Palut D Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657 [TBL] [Abstract][Full Text] [Related]
4. An overview of peroxisome proliferator-induced hepatocarcinogenesis. Rao MS; Reddy JK Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443 [TBL] [Abstract][Full Text] [Related]
5. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation. Vanden Heuvel JP Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056 [TBL] [Abstract][Full Text] [Related]
6. Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease. Youssef J; Badr M Crit Rev Toxicol; 1998 Jan; 28(1):1-33. PubMed ID: 9493760 [TBL] [Abstract][Full Text] [Related]
7. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Reddy JK; Lalwai ND Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536 [TBL] [Abstract][Full Text] [Related]
8. Peroxisomal lipid metabolism. Reddy JK; Mannaerts GP Annu Rev Nutr; 1994; 14():343-70. PubMed ID: 7946524 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferators: a model for receptor mediated carcinogenesis. Green S Cancer Surv; 1992; 14():221-32. PubMed ID: 1330305 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferators: their biological and toxicological effects. Dzhekova-Stojkova S; Bogdanska J; Stojkova Z Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454 [TBL] [Abstract][Full Text] [Related]
17. [The contribution of peroxisomes to lipid metabolism]. Kramar R J Clin Chem Clin Biochem; 1986 Feb; 24(2):109-18. PubMed ID: 3711795 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. Lake BG Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126 [TBL] [Abstract][Full Text] [Related]
19. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Reddy JK; Rao MS Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702 [TBL] [Abstract][Full Text] [Related]